Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adaptation to Neonatal Life After an Anesthetic Protocol Using Remifentanil for General Anesthesia for Caesarean Section in a Context of Prematurity - REAGI Protocol

NCT02029898 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02029898
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02029898 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adaptation to Neonatal Life After an Anesthetic Protocol Using Remifentanil for General Anesthesia for Caesarean Section in a Context of Prematurity - REAGI Protocol
Lead sponsor
University Hospital, Rouen
Phase
Phase 1/2
Overall status
Completed
Start date
February 2, 2014
Completion date
June 22, 2018
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anesthesia, cesarean section